Ten "new policies" to encourage the development of Qingdao's biomedical industry

[policies and regulations of pharmaceutical network] a single drug variety from new drug research and development to industrialization can get up to 50 million yuan of funding! Recently, the general office of Qingdao municipal government issued the notice on several policies and measures to support the high-quality development of the biomedical industry, marking that the city's biomedical industry ushered in a huge era of policy dividend According to the industry, this is a biomedical industry support policy that has been issued in Qingdao since the beginning of its history, covering all aspects of the industrial chain such as new drug research and development, industrialization, project investment, market sales, etc All 10 policies, aiming at the industrial pain points, are among the top in terms of support strength and coverage, which will help boost Qingdao's biomedical industry to be bigger and stronger, as well as boost the confidence of relevant enterprises in the island city to help prevent and control the epidemic Ten policies involve encouraging new drug innovation, supporting research and development of medical devices, developing traditional Chinese medicine and special medical food, accelerating the transformation of innovation achievements, introducing leading enterprises in the industry, supporting enterprises to grow and strengthen, supporting the application of medical device products, promoting the construction of service platform, encouraging relevant qualification certification, and promoting enterprises to explore the market The ten supporting policies are divided into four parts, among which there are two major aspects in encouraging industrial innovation For example, according to the policy, if Qingdao has completed preclinical research on class 1 chemical drugs, biological products, traditional Chinese medicine and natural drugs and obtained clinical acceptance number or default clinical treatment, it will be given a maximum of 1 million yuan for each item; if it has completed phase I, phase II and phase III clinical trial research, it will be given a maximum of 3 million yuan, 6 million yuan and 20 million yuan respectively according to 20% of the actual investment in research and development expenses According to different standards, subsidies will be given at different stages for 2 types of chemical drugs, 2-8 types of biological products, 2-8 types of traditional Chinese medicine and natural drugs, 3-4 types of chemical drugs, 1-3 types of new veterinary drugs, etc We will encourage the development of medical devices, traditional Chinese medicine and special medical foods, and grant up to 10 million yuan to eligible three types of medical devices It is understood that this policy is applicable to enterprises, relevant institutions, social organizations or non-governmental non enterprises that are registered in Qingdao and have independent legal personality and engaged in research and development, production and service of medicine and medical devices This notice shall be implemented from the date of issuance and shall be valid until February 7, 2023 In case of adjustment of national, provincial and relevant policies and regulations during the implementation period, such regulations shall prevail It is understood that the biomedical industry is one of the key industries in Qingdao Taking Qingdao high tech Zone as an example, there is a blue biomedical science and technology park covering an area of 3700 mu, including 120000 square meters of Qingdao blue biomedical industrial park, 545 mu of Shandong University International Industrial Park integrating innovation park, Incubation Park and Industrial Park, and the marine characteristic industrial park of Qingdao Blue Economic zone At the same time, Qingdao high tech Zone has also built a number of R & D platforms for biomedical industry, including large-scale biomedical professional incubation center, national and local joint Engineering Research Center for stem cell biological diagnosis and treatment, Qingdao public R & D service platform for biomedical engineering and technology, etc In order to ensure the sustainable development of the medical and pharmaceutical industry, Qingdao hi tech Zone has also built Qingdao biomedical maker space "shell biology", led the establishment of Qingdao Biomedical Industry Chamber of Commerce and Qingdao Marine biomedical industry innovation alliance, providing a platform for mutual benefit and mutual assistance for the development of the biomedical industry in Qingdao With the development of economy, the change of living environment, the change of people's health concept and the acceleration of the aging process of population, the biomedical industry closely related to the quality of human life has maintained a sustained growth trend in recent years Biopharmaceutical industry has also become a strategic emerging industry competing for development With the introduction of the "blue medicine storehouse" development plan in Qingdao, its biomedical industry has entered the fast lane of development The introduction of several policies and measures to support the high-quality development of the biomedical industry will once again promote the development of Qingdao's biomedical industry, and at the same time, the development of policies will also bring confidence to the epidemic prevention and control